ArticleCancers2023

Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.

Riaz Jannoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.